| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |